Aeterna Zentaris Inc
TSX:AEZS

Watchlist Manager
Aeterna Zentaris Inc Logo
Aeterna Zentaris Inc
TSX:AEZS
Watchlist
Price: 5.1 CAD -0.97% Market Closed
Market Cap: 18.9m CAD

Aeterna Zentaris Inc
Effect of Foreign Exchange Rates

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Aeterna Zentaris Inc
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
Aeterna Zentaris Inc
TSX:AEZS
Effect of Foreign Exchange Rates
-$38k
CAGR 3-Years
49%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Effect of Foreign Exchange Rates
-$15m
CAGR 3-Years
49%
CAGR 5-Years
4%
CAGR 10-Years
32%
Gilead Sciences Inc
NASDAQ:GILD
Effect of Foreign Exchange Rates
$32m
CAGR 3-Years
N/A
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Effect of Foreign Exchange Rates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Effect of Foreign Exchange Rates
$36.3m
CAGR 3-Years
N/A
CAGR 5-Years
34%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Effect of Foreign Exchange Rates
-$100k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Aeterna Zentaris Inc
Glance View

Market Cap
18.9m CAD
Industry
Biotechnology

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The company is headquartered in Montreal, Quebec and currently employs 17 full-time employees. The firm's lead product, Macrilen (macimorelin), is an oral test indicated for the diagnosis of patients with adult growth hormone deficiency (AGHD). Macrilen (macimorelin) is an orally available peptidomimetic ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the ghrelin receptor (GHSR-1a) and has uses in both endocrinology and oncology indications. The firm is also leveraging the clinical and compelling safety profile of macimorelin to develop it for the diagnosis of childhood-onset growth hormone deficiency (CGHD). The company is also developing oral prophylactic bacterial vaccines against each of SARS-CoV-2, the virus that causes COVID-19, and Chlamydia Trachomatis. The firm focuses on the commercialization of macimorelin in Asia and the rest of the world.

AEZS Intrinsic Value
Not Available

See Also

What is Aeterna Zentaris Inc's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
-38k USD

Based on the financial report for Mar 31, 2024, Aeterna Zentaris Inc's Effect of Foreign Exchange Rates amounts to -38k USD.

What is Aeterna Zentaris Inc's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 5Y
24%

Over the last year, the Effect of Foreign Exchange Rates growth was 94%. The average annual Effect of Foreign Exchange Rates growth rates for Aeterna Zentaris Inc have been 49% over the past three years , 24% over the past five years .

Back to Top